Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedLocations have been reorganized with many new location groupings added (e.g., Brussels Capital, Czech Republic, Kent, Madrid, Valencia, etc.). Several previously listed location groups (e.g., Brussels Capital Locations, BGR Locations, Czech Republic Locations) were removed.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated to v3.3.2, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0; no substantive changes to study content, layout, or navigation are evident in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange Detected- Removed the generic government operating status notice from the page. The remaining study details, endpoints and contact information remain unchanged.SummaryDifference0.1%

- Check63 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page. The page content remains unchanged.SummaryDifference0.2%

- Check92 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. If no other substantive content changed, this is a minor but status/reliability-related update.SummaryDifference1%

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.